Infections invasives à méningocoque

Invasive meningococcal infections

Invasive meningococcal infections are associated with significant morbidity and mortality. Reporting and surveillance of these infections are intended to strengthen prevention efforts against this disease.

Our Mission

  • Describe the epidemiology of invasive meningococcal infections

  • Detect clusters of cases and unusual situations

  • Assess and monitor vaccination coverage

  • Promote vaccination against invasive meningococcal C infections for infants and adolescents

vaccination-info-service.fr - Le site de référence qui répond à vos questions

The disease

Invasive meningococcal infections

Meningococcus is a bacterium found exclusively in humans and is a commensal of the nasopharynx. It possesses a polysaccharide capsule that determines its serogroup. Among the twelve described serogroups, strains of serogroups A, B, C, Y, and W are responsible fo...

Learn more

What We Do

Santé publique France is responsible for the epidemiological surveillance of IIM, which makes it possible to describe the characteristics of patients, monitor trends in transmission within the population, detect any abnormal situations early on, and, if necessary, implement measures to prevent r...

Learn more

Data

The surveillance conducted by Santé publique France makes it possible to track trends in the incidence rate, monitor patient characteristics, and identify abnormal situations.

Learn more

Tools

Here you will find the resources (videos, TV spots, radio spots) and prevention materials made available to healthcare professionals and the general public

depliant/flyer

Meningococcal Meningitis and Septicemia: 5 Good Reasons to Get Vaccinated. ...

This brochure, intended for parents of children ages 11 to 14, provides information on invasive meningococcal infections and vaccination recommendations to protect against them.

Download Visualize Order

brochure

Meningococcal Meningitis and Septicemia: 5 Good Reasons to Get Vaccinated

Brochure for parents of infants, regarding the first dose at 3 months for type B and at 6 months for types ACWY. Distributed to healthcare professionals.

Download Visualize Order

Publications

Here you will find the latest scientific publications related to the studies and research conducted by Santé publique France.

2 publications

In relation to

Vaccination

Vaccination

thematic dossier

Contagious diseases most often affect children at a very young age. Because children are particularly vulnerable, they are a priority target for vaccination programs.

Learn more